Product Details

Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 50/300/300 mg Tablets**

Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate
50 mg; 300 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Oxus Pharma Ltd

NRN

C4-1704

Status

Active


Composition

Dolutegravir (sodium)/Lamivudine/Tenofovir disoproxil fumarate 50 mg/300 mg/300 mg Tablets. Each film coated tablet contains: Dolutegravir Sodium equivalent to Dolutegravir 50 mg, Lamivudine USP 300 mg, Tenofovir Disoproxil Fumarate 300 mg equivalent to 245 mg of Tenofovir Disoproxil  

ATC Code

J05AR27  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 30's;1 x 90's (in HDPE bottles)  

Product Description

Film coated Tablets

Manufacturer Name

Macleods Pharmaceuticals Ltd.

Manufacturer Country

INDIA  

Approval Date

2024-10-31  

Expiry Date

2029-10-30